Cassano, G.B., Fagiolini, A., Lattanzi, L., Monteleone, P., Niolu, C., Sacchetti, E., Siracusano, A. and Vita, A. (2007) Aripiprazole in the treatment of schizophrenia: A consensus report produced by schizophrenia experts in Italy. Clinical Drug Investigation, 27, 1-13. doi:10.2165/00044011-200727010-00001

has been cited by the following article:

• TITLE: Withdrawal seizure associated with high dosage of aripiprazole and fluoxetine: a case report

  AUTHORS: Jian-An Su, Shih-Yong Chou, Ching-Shu Tsai, Tai-Hsin Hung

  KEYWORDS: Aripiprazole; High Dosage; Withdrawal Seizure

  JOURNAL NAME: Open Journal of Psychiatry, Vol.1 No.2, July 12, 2011

  ABSTRACT: Aripiprazole, a third-generation antipsychotic, has been considered to have a high safety profile and rare withdrawal symptoms. We reported the case of a schizophrenic patient with a significant obsession, who was treated with a high dosage of aripiprazole and fluoxetine. Generalized tonic-clonic seizure occurred two days after abruptly stopping these two medications. Gradually tapering aripiprazole is suggested in clinical practice, especially when using a high dosage.